Catalyst Wire Dossier Catalyst Wire Dossier
FDA approval · 2021-01-21

FDA Approved: NITROFURANTOIN MONOHYDRATE/ MACROCRYSTALLINE — Supplemental Application (Alvogen Inc.)

View source ↗

Summary

The FDA approved a supplemental application for nitrofurantoin monohydrate/macrocrystalline (Alvogen). This action confirms regulatory authorization for the pro…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Nitrofurantoin monohydrate/macrocrystalline (Nitrofurantoin monohydrate/macrocrystalline)

Snippet

SUPPL AP for NITROFURANTOIN MONOHYDRATE/ MACROCRYSTALLINE (NITROFURANTOIN MONOHYDRATE/MACROCRYSTALLINE)